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Transcription factor AP-2a has been implicated as of intermediate filaments expressed. This suggests
that despite the results from other analyses, loss ofbeing a cell-type-specific regulator of gene expression
during vertebrate embryogenesis based on its expres- transcription factor AP-2a does not affect the expres-
sion of intermediate filaments in the skin of newbornsion pattern in neural crest cells, ectoderm, and the
nervous system in mouse and frog embryos. In mice, animals. We found an altered spatial distribution of
intermediate filament expression in the single layeredAP-2a is expressed in surface ectoderm beginning at
the single cell layer state around E8.75. AP-2a-deficient cranial ectoderm during days 9–12 of gestation leading
to an evenly distributed expression of keratin 5 and 15mice, derived by targeted mutagenesis, display a severe
ventral closure defect resulting in cranio-abdomino- in the mutants. Furthermore, the mutants lack a ring
of ectodermal cells highly positive for keratin 15 inschisis and a hypoplasia of the cranial ganglia. This
study analyzed the effect of a targeted disruption of the area where lens induction occurs, indicating a
defect in the inductive interactions underlying eyethe AP-2a gene on the architecture and the expression
of intermediate filaments in skin. We analyzed skin formation. Key words: intermediate filaments/skin develop-
ment/targeted mutant/transcription factor AP-2α. J Investsamples from newborn mice and found no difference
in either the morphology of the skin or the amount Dermatol 113:816–820, 1999
T filaments (Leask et al, 1991; Magnaldo et al, 1993; Byrne and Fuchs,1993). Sequence analyses has revealed AP-2 binding motifs in thekeratin 1, 5, 6b, 14, and 15 genes. Gel shift analyses showed thatAP-2 protein binds to the promoter of the keratin 5 and 14 genes.Moreover, in HepG2 cells, a human liver carcinoma cell line, the
promoter of keratin 14 can be activated upon cotransfection with
he family of AP-2 transcription factors consists of
three different genes known as AP-2α, β, and γ
(Williams et al, 1988; Moser et al, 1995; Chazaud
et al, 1996; McPherson et al, 1997). AP-2 transcription
factors homodimerize using a unique C-terminal
helix–span–helix motif (Williams and Tjian, 1991b). Sequence
AP-2 (Leask et al, 1991). Furthermore, it was shown that inspecific binding to the consensus GCCN(3/4)GGC is mediated by
developing skin the expression pattern of AP-2α precedes thea basic domain that overlaps with the dimerization domain.
expression of the basal type keratin 5 (Byrne and Fuchs, 1993).Transcriptional activation is mediated by a proline/glutamine rich
Thus, regulation of keratin genes by transcription factor AP-2α iscassette at the N-terminus (Williams and Tjian, 1991a). These
based on: (i) presence and usage of AP-2 binding sites in thedomains are highly conserved in all three known AP-2 genes.
promoters of keratin genes; (ii) activation of keratin promoters inRetinoic acid treatment induces transcription of AP-2 genes,
transient transfection studies; and (iii) the spatiotemporal expressionleading to a higher level of AP-2 activity (Luscher et al, 1989),
pattern of basal keratins which follow the expression of AP-2α inwhereas treatment with protein kinase C and cyclic adenosine
the developing skin.monophosphate also results in higher activity of AP-2, but without
Here we have used mice deficient for AP-2α (Schorle et al, 1996)altering the mRNA or protein levels (Imagawa et al, 1987).
to analyze skin development using morphologic, histochemical, andDuring development, expression of AP-2α initiates around day
protein analyses of intermediate filaments. The pattern of theE (day of embryonic development) 8.75 in the single layered
overall expression of keratins was unchanged in the skin of E18.5surface ectoderm (Mitchell et al, 1991). Later, AP-2α expression
animals as judged by Coomassie and western blot. Examination oflocalizes to the basal layer of the developing skin, where it persists
keratin 5 and 15 expression during earlier stages of developmentin the adult animal (Mitchell et al, 1991; Leask et al, 1991; Moser
revealed that the distinct spatial expression pattern of these basalet al, 1997). In ectodermal cells, transcription factor AP-2 has been
type keratins is altered. In addition, whole mount staining forimplicated in regulating the expression of a variety of intermediate
keratin 15 showed that a ring of epithelial cells highly positive for
keratin 15 in controls and indicative for the area of the induction
of the lens placode, is absent in AP-2α mutants. This suggests thatManuscript received March 10, 1999; revised June 18, 1999; accepted
lens induction, a process initiated by contact of neuroepitheliumfor publication August 5, 1999
and surface ectoderm did not take place (West-Mays et al, 1999).Reprint requests to: Dr. H. Schorle, Forschungszentrum Karlsruhe,
Institut for Toxicology and Genetics, Hermann von Helmholtz Platz 1, MATERIALS AND METHODS
76344 Eggenstein-Leopolshafen, Germany. Email: hubert.schorle@igen.
fzk.de Whole mount antibody staining of embryos The method of whole
mount antibody staining of embryos was performed as described (SchorleAbbreviations: E, days of embryonic development
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et al, 1996). Briefly, embryos were isolated in cold phosphate-buffered PBS, the embryos were postfixed in 10% formalin and photographed using
saline (PBS) and fixed in methanol–dimethylsulfoxide (4:1) for 12 h at a Zeiss Stereomicroscope.
4°C with gentle agitation. The embryos were then bleached in methanol–
dimethylsulfoxide–30% H2O2 (4:1:1) for 5 h and rinsed in three changes Detection of melanoblasts Detection of migrating melanoblasts wasof PBSMT (PBS, 2% skim milk powder, 0.1% Triton X100). The first performed as described (Hirobe and Takeuchi, 1977). Briefly, pieces ofantibody was used at 1:300 dilution and incubated for 12 h at 4°C. After skin were excised from the dorsal side of E18.5 animals and fixed in 10%three rinses with PBSMT, a peroxidase coupled secondary antibody neutral buffered formalin for 24 h at 4°C. The pieces were rinsed with(Boehringer Mannheim, Indianapolis, IN) was used at 1:500 dilution and
distilled water and incubated with 0.1% dihydroxyphenylalanine in PBSincubated for 12 h at 4°C. The embryos were then washed two times in
for 24 h at 37°C. The material was then processed and embedded andPBSMT and finally in PBT (PBS, 0.2% BSA) and incubated with 0.3 mg
hematoxylin and eosin stained sections were examined and photographeddiaminobenzidine per ml for 20 min. The color reaction was induced by
using a Leica Labovert microscope.adding H2O2 to 0.03%. The reaction was stopped by several changes of
Histochemistry in sections Skin from the dorsal part (hairy skin) as
well as skin from paws (non-hairy skin) was excised, fixed in 10% neutral
buffered formalin, processed in paraffin wax, and sectioned. Sections were
dewaxed in xylene, the antigens were unmasked by boiling the slides for
5 min in tap water in a microwave oven. The sections were rinsed with
PBS containing 0.1% bovine serum albumin, the primary antibodies (gift
from E. Fuchs, Chicago, IL) were applied for 20 min. After three washes
in PBS the secondary antibody was applied for 15 min and detected using
0.3 mg diaminobenzidine per ml and 0.05% H2O2. The slides were
examined and photographed using a Leica Labovert Microscope.
Intermediate filament extractions In order to extract the intermediate
filaments from the epidermis, backskin samples were excised and floated,Figure 1. AP-2a-deficient animals develop cranio-abdomino-
dermis side down in 2 M NaBr at 37°C for 15 min. The epidermis wasschisis. (a) Side view of a control. (b) Side view and (c) frontal view of
then separated from the dermis with forceps, pulverized in a mortar onan animal deficient for AP-2α. Arrow in (b) indicates the rostal border of
dry ice, homogenized with a sonicator set to 20 pulses in Solution Athe skin, the neural anterior neural tube as well as the neuroepithelium of
(20 mM Tris–HCl pH 7.4, 0.6 M KCl, 1% Triton X100, 0.3 mgthe brain is not covered by skin. Arrow in (c) indicates brain tissue not
phenylmethylsulfonyl fluoride per ml) centrifuged at 14,0003 g for 15 mincovered by skin.
at 4°C. The supernatant was discarded and the sonication/centrifugation
was repeated twice. The final pellet was resuspended in 9 M urea, 20 mM
Tris pH 7.5, 10% β-mercaptoethanol and 0.3 mg phenylmethylsulfonyl
fluoride per ml.
Western blots The extracted intermediate filaments were run on a 7.5%
sodium dodecyl sulfate–polyacrylamide gel electrophoresis protein gels
(Bio-Rad, Hercules, CA) using standard conditions (Laemmli, 1970). The
gel was stained with Coomassie to evaluate the amount of keratins
present. For western blots the proteins were blotted on to nitrocellulose,
incubated with the primary antibody (1:2000 dilution) in TBSMT (50 mM
Tris pH 7.6, 150 mM NaCl, 5% skim milk powder, 0.2% Triton X100)
overnight at 4°C, washed three times in TBSMT, and incubated with the
secondary antibody (horseradish peroxidase conjugated, Promega, Madison,
WI, 1:20,000 dilution) for 1 h. The blot was washed once in TBSMT,Figure 2. Migration and maturation is not affected in AP-2a-
once in TBST (TBS with 0.2% Triton X100), once in TBSN (TBS withdeficient animals. Skin sections of backskin of newborn wild-type
0.1% NP-40), and twice with PBS (Vassalli et al, 1994). The signal(a, 1/1) and AP-2α-deficient (b, –/–) animals was processed for the
was detected using the ECL system according to the manufacturer’sL-dihydroxyphenylalanine reaction described. The brown spots indicate
melanoblasts (arrows in a and b). recommendations (Amersham, Bucks, UK).
Figure 3. The spatial expression of intermediate filaments is not affected in AP-2a-deficient animals. Backskin of newborn wild-type (a–g,
1/1) and AP-2α-deficient (h–n, –/–) animals was processed for antibody staining as indicated.
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RESULTS AND DISCUSSION
Examination of whole embryos In order to detect defects
gross morphology of the skin, we first analyzed whole embryos up
until birth. Figure 1 shows an E16.5 wild-type (Fig 1a) and an
AP-2α-deficient embryo (Fig 1b, c). Owing to the cranial and
ventral closure defect the skin does not cover the brain and the
inner organs. The gut, liver, and the heart can be seen protruding
from the embryo (Fig 1c). The overall appearance of the skin is
normal and there is no blistering or blebbing evident.
Skin morphology as well as the population of the skin with
melanocytes is unaffected Next, we generated sections of paw
skin as well as hairy skin to analyze the morphology of the skin.
Figure 2 shows hematoxylin and eosin stained section of wild-
type (Fig 2a) and mutant (Fig 2b) skin. As one can see, there is
no difference in the architecture of the dermis and epidermis.
Additionally, reaction with L-DOPA was performed to detect
immature melanocytes. Migration and maturation of melanocytes
seems to be unaffected. These data indicate that the loss of AP-2α
does not affect the morphology of the skin per se. Furthermore,
the melanocytes, a derivative of the neural crest cells, do not show
any signs of altered migration or proliferation. It has been shown
that loss of AP-2α in a melanoma cell line can lead to increased
malignancy, thus leading to the proposal that AP-2α in fact acts as
a tumor suppressor gene (Bar-Eli, 1997; Huang et al, 1998). Under
normal physiological conditions, however, we do not see any
aberrant behavior of melanoblasts in knockout animals or even
melanocytes in chimeric animals generated with AP-2α –/– cells
(data not shown).
Our results indicate that loss of this transcription factor alone is
not sufficient to lead to malignant transformation of melanocytes.
The spatial expression of intermediate filaments in skin of
AP-2a mutants is not affected As AP-2α is expressed in the
basal layer of the skin, we next analyzed the spatial expression
pattern of various intermediate filaments which are expressed in
basal and suprabasal levels of skin. Figure 3 shows sections of wild-
type (Fig 3a–g) and mutant (Fig 3h–n) skin stained with various
antibodies. Keratin 5 (Fig 3b, i) is expressed strongly in basal cells
and becomes downregulated within the cells of the suprabasal
levels. Keratins 14 (Fig 3c, j) and 15 (Fig 3d, k) are found in basal
Figure 4. The amount of intermediate filaments made in skin ofcells only. Detection of intermediate filaments specific for suprabasal
AP-2a-deficient mice is unaffected. (a) Shows a Coomassie-stainedcells, such as keratin 10/11 (Fig 3e, l), keratin 18 (Fig 3f, m), and
protein gel of extracted intermediate filaments of newborn animals. Theloricrin (Fig 3g, n), could also not reveal any difference between
genotype is indicated by (1/1) wild-type, (1/–) heterozygous, and (–/–)wildtype and mutants. This is interesting as it has been shown that deficient for AP-2α gene. (b–d) Show antibody staining with the anti-
truncation of a human keratin 5 promoter lacking AP-2 binding serum indicated.
sites results in a shift of keratin 5 expression from basal to suprabasal
levels in the skin (Byrne and Fuchs, 1993). Obviously, in the loss
of function mouse model analyzed here, other factors besides AP-
2α are able to compensate and direct the correct spatial expression of the onset and spatiotemporal distribution of expression of the
pattern of the intermediate filaments. keratins 5 and 15. It has been reported that the expression of AP-
2α in the skin precedes the expression of keratin 5, suggesting thatThe level of intermediate filaments is unaltered in skin of
establishment of AP-2α expression is necessary to initiate expressionAP-2a-deficient mice We reasoned that loss of AP-2α might
of keratin 5. We performed a series of whole mount antibodyhave an effect on the level of intermediate filament protein made
stainings with embryos aged E9.5 (Fig 5a, d), E10.5 (Fig 5b, e)in the skin of mutant mice. Therefore, we extracted the intermediate
and E12.5 (Fig 5c, f). At E9.5, the expression pattern of keratin 5filaments from the backskin of newborn animals and subjected
is set up in a regular fashion and the staining of the apical ectodermalthem to protein gel analysis (Fig 4a) as well as western blot (Fig
ridge in the limb buds as well as the distinct staining of the4b–d). We analyzed three wild-type animals [lanes 2, 4, and 8 (1/
ectoderm lining the borders of the somites is apparent (arrows in1)], three animals heterozygous [lanes 1, 3, and 7 (1/–)], and two
Fig 5a, d). At E10.5, expression of keratin 5 in the head of theanimals nullizygous for the AP-2α mutation [lanes 4 and 5 (–/–)].
wild-type embryo (Fig 5b) is more pronounced in the frontonasalThe protein gel stained with Coomassie nicely shows that there is
mass and less prominent in the surface ectoderm of the cranialno difference in amounts of keratins expressed. As AP-2α is
region. The mutant animal, however, shows a reduced expressionexpressed in the basal layer, we decided to have a closer look at
of keratin 5 in the frontonasal region (Fig 5e, arrow) This mightthe basal keratins 5, 14, and 15 using western blots. Here too, no
be a result of the mutant phenotype whereby the maxillary anddifference could be detected, indicating that the level of intermediate
the mandibular buds are slightly retarded in growth and as afilament protein is not dependent on the presence of AP-2α under
consequence, fail to fuse in the midline resulting in the facialphysiologic conditions.
clefting. At E12.5, the wild-type embryo shows a pronounced
spatial distribution of the expression of keratin 5, the cranial vaultSpatiotemporal distribution of intermediate filaments during
development The last part of our analysis dealt with the question shows almost no keratin 5 expression and the ectoderm of the
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Figure 5. Expression of keratin 5 is disturbed
in AP-2a-deficient mice. Whole mount antibody
staining with a keratin 5 specific antibody was per-
formed as described. (a–c) Represent wild-type
embryos; (d–f) represent AP-2α-deficient embryos.
The age of the embryos is indicated (E9.5, E10.5,
and E12.5).
frontonasal mass shows a strong keratin 5 signal (Fig 5c). In mutants,
this spatial distribution cannot be seen, and the expression is evenly
distributed in surface ectoderm (Fig 5f). In addition, expression of
keratin 5 is strongly upregulated in the developing neuroepithelium
at E12.5 (Fig 5f, arrow). These differences between wild-type and
mutant animals could indicate that AP-2α plays a part in fine
tuning of the spatial expression of intermediate filaments.
The analysis of the expression of keratin 15 at E9.5 at E9.5 (Fig
6a, b) revealed an interesting detail. The expression in the first
branchial arch seems to be upregulated (arrow II). Furthermore, a
ring of cells (arrow I in Fig 6a), which mark the site where the
lens induction has taken place in wild-type embryos, cannot be
seen in mutants (Fig 6b, arrow I). This indicates that the induction
of the lens had failed (West-Mays et al, 1999). The neuroepithelium Figure 6. Expression of keratin 15 is altered in AP-2a-deficient
in the mutant shows strong expression of keratin 15 at E9.5. animals due to failure of lens induction. (a) Wild-type and (b) AP-
2α-deficient embryo head at E9.5 were subjected to whole mount antibodyCONCLUSIONS staining. Arrow I indicates the site of lens induction in wild-type and the
lack thereof in mutant animals. Arrow II points to the first branchial archTranscription factor AP-2α has been implicated as being one of
where the wild-type has less expression compared with the AP-2α-the regulators of intermediate filament expression in the skin. Here
deficient animal.we have utilized a mouse model which has been rendered AP-2α-
deficient by targeted mutagenesis. We analyzed the morphology of
the skin as well as the expression pattern and amount of intermediate
filaments present. Studies showed that expression of AP-2 in that AP-2α acts as a tumor suppressor gene for this type of cancer
(Bar-Eli, 1997; Huang et al, 1998; Jean et al, 1998). In ourHepG2 cells is able to induce expression of a reporter gene driven
by the human keratin 14 promoter (Bryne et al, 1994). Furthermore, experiments, however, we do not see any signs of malignant
transformation of melanoblasts in the skin of newborn animals. Inthe expression pattern of keratin 5 follows strictly the expression
pattern of AP-2 in the developing skin (Bryne and Fuchs, 1993) addition, melanocytes derived from AP-2α-deficient ES cells do
not display any aberrant behavior in adult chimeric animals. Thus,implicating a positive regulation by AP-2 of the basal type keratins
5 and 14. Our analyses show clearly that loss of AP-2α does not under physiological conditions, loss of AP-2α does not lead to
malignant transformation of melanoblasts or melanocytes.lead to an altered spatial expression of the keratins in the basal or
suprabasal layer of the skin. This indicates that other factors such When we analyzed early embryos for the onset of expression of
keratins 5 and 15, we found that the spatially defined expressionas AP-2β and AP-2γ might compensate for the loss of this
transcription factor. We are currently working towards establishing pattern in the head of mutant embryos is altered. The loss of the
ring of cells positive for keratin 15 is a secondary effect whicha mouse model which lacks both AP-2α and AP-2β genes in order
to investigate compensatory mechanisms. Analogous experiments results from the loss of lens placode induction. Loss of induction
of the lens placode in AP-2α mutant animals has been describedwill be performed once the AP-2γ-deficient mouse line is available.
It was shown recently that the loss of AP-2α in a human recently (West-Mays et al, 1999). The AP-2α-deficient animals do
not show strong expression of keratin 5 in the facial primordiamelanoma cell line leads to increased malignancy. It was discussed
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two different signal-transduction pathways: protein kinase C and cAMP. Cellcompared with wild-type controls at E10.5 and E12.5. As the
51:251–260, 1987development of the facial primordia is greatly distorted in the Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, Bar-Eli M:
mutant mice, the dysregulated expression of keratins 5 and 15 Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in
tumor growth and metastasis of human melanoma cells. J Biol Chem 273:16501–might be a secondary defect.
16508, 1998This study, together with other studies on regulation of keratin
Laemmli UK: Cleavage of structural proteins during the assembly of the head ofgene expression will help us to understand the complex network bacteriophage T4. Nature 227:680–685, 1970
of signals which is needed to establish correct expression of Leask A, Byrne C, Fuchs E: Transcription factor AP2 and its role in epidermal-
specific gene expression. Proc Natl Acad Sci USA 88:7948–7952, 1991intermediate filaments in the skin.
Luscher B, Mitchell PJ, Williams T, Tjian R: Regulation of transcription factor
AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev
3:1507–1517, 1989
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